# Pilocarpine in Treating Patients With Dry Mouth Caused by Opioids

> **NCT00003686** · PHASE3 · TERMINATED · sponsor: **NCIC Clinical Trials Group** · enrollment: 4 (actual)

## Conditions studied

- Oral Complications
- Quality of Life

## Interventions

- **DRUG:** pilocarpine hydrochloride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00003686
- **Lead sponsor:** NCIC Clinical Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1998-05-22
- **Primary completion:** 2007-11-01
- **Final completion:** 2008-12-15
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Terminated due to poor accrual.
- **Last updated:** 2020-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003686, "Pilocarpine in Treating Patients With Dry Mouth Caused by Opioids". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00003686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*